Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 411036
                    [Title] => Delaying diabetic retinopathy
                    [Summary] => The results of the FIELD (Fenofibrate Intervention and Event Lowering in Diabetes) study confirmed fenofibrate’s ...
                    [DatePublished] => 2008-10-30 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 57893
                    [Title] => Treating diabetic retinopathy
                    [Summary] => 
            
                    [DatePublished] => 2008-04-24 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [2] => Array
                (
                    [ArticleID] => 289788
                    [Title] => Managing metabolic syndrome with ‘fenofibrates’
                    [Summary] => Fenofibrate has been shown to reduce risk of coronary events, including non-fatal heart attack and stroke, in patients with metabolic syndrome. 


A study demonstrated the benefits of fenofibrate therapy in atherogenic dyslipidemia, a common risk factor for metabolic syndrome, a constellation of risk factors which also include obesity, insulin resistance and hypertension.


Atherogenic dyslipidemia is characterized by high-triglycerides, low high-density lipoprotein (HDL) and the preponderance of small low-density lipoprotein.  


                    [DatePublished] => 2005-08-04 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [3] => Array
                (
                    [ArticleID] => 257636
                    [Title] => Stopping the world’s top killer
                    [Summary] => Wary of eating fast food that’s rich in fat, yet can’t seem to find the will power to avoid them? Perhaps it might be helpful to know that the incidence of coronary artery disease (CAD) has reached epidemic proportions, making it a consistent top killer worldwide. 


CAD develops when there is plaque buildup in the arteries, thus diminishing the supply of oxygen and nutrients to the heart. This may eventually lead to angina (chest pain) or sudden death.


                    [DatePublished] => 2004-07-15 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

FENOFIBRATE

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 411036
                    [Title] => Delaying diabetic retinopathy
                    [Summary] => The results of the FIELD (Fenofibrate Intervention and Event Lowering in Diabetes) study confirmed fenofibrate’s ...
                    [DatePublished] => 2008-10-30 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 57893
                    [Title] => Treating diabetic retinopathy
                    [Summary] => 
            
                    [DatePublished] => 2008-04-24 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [2] => Array
                (
                    [ArticleID] => 289788
                    [Title] => Managing metabolic syndrome with ‘fenofibrates’
                    [Summary] => Fenofibrate has been shown to reduce risk of coronary events, including non-fatal heart attack and stroke, in patients with metabolic syndrome. 


A study demonstrated the benefits of fenofibrate therapy in atherogenic dyslipidemia, a common risk factor for metabolic syndrome, a constellation of risk factors which also include obesity, insulin resistance and hypertension.


Atherogenic dyslipidemia is characterized by high-triglycerides, low high-density lipoprotein (HDL) and the preponderance of small low-density lipoprotein.  


                    [DatePublished] => 2005-08-04 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [3] => Array
                (
                    [ArticleID] => 257636
                    [Title] => Stopping the world’s top killer
                    [Summary] => Wary of eating fast food that’s rich in fat, yet can’t seem to find the will power to avoid them? Perhaps it might be helpful to know that the incidence of coronary artery disease (CAD) has reached epidemic proportions, making it a consistent top killer worldwide. 


CAD develops when there is plaque buildup in the arteries, thus diminishing the supply of oxygen and nutrients to the heart. This may eventually lead to angina (chest pain) or sudden death.


                    [DatePublished] => 2004-07-15 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

abtest

Delaying diabetic retinopathy

October 30, 2008 - 12:00am

The results of the FIELD (Fenofibrate Intervention and Event Lowering in Diabetes) study confirmed fenofibrate’s ...

Science and Environment

Treating diabetic retinopathy

April 24, 2008 - 12:00am

Science and Environment

Managing metabolic syndrome with ‘fenofibrates’

August 4, 2005 - 12:00am

Fenofibrate has been shown to reduce risk of coronary events, including non-fatal heart attack and stroke, in patients with metabolic syndrome. A study demonstrated the benefits of fenofibrate therapy in atherogenic...

Science and Environment

Stopping the world’s top killer

July 15, 2004 - 12:00am

Wary of eating fast food that’s rich in fat, yet can’t seem to find the will power to avoid them? Perhaps it might be helpful to know that the incidence of coronary artery disease (CAD) has reached epidemic...

Science and Environment